Back to 
Baker Bros. Advisors LP
Baker Bros. Advisors LP
AR2
Showing 0 of 3 quarters
Position history for Baker Bros. Advisors LP's holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, Baker Bros. Advisors held 2,848,567 shares of AR2 (Array Biopharma), worth $132M. Baker Bros. Advisors' 13F filings listed AR2 from Q1 2019 to Q2 2019, 2 quarterly filings. AR2 was 0.9% of Baker Bros. Advisors' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.